Your browser doesn't support javascript.
loading
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi, Leila; Mahoutforoush, Amin; Dorreyatim, Seyed Sina; Soltanfam, Tannaz; Paiva-Santos, Ana Cláudia; Peixoto, Diana; Veiga, Francisco; Hamishehkar, Hamed; Zeinali, Mahdi; Abbaspour-Ravasjani, Soheil.
Affiliation
  • Asadollahi L; Student Research Committee and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electron
  • Mahoutforoush A; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: A.mahoutfroush@aut.ac.ir.
  • Dorreyatim SS; Student Research Committee and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: S.dorreyatim@gmail.com.
  • Soltanfam T; Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Research and Development Unit, Daana Pharma Co, Tabriz, Iran. Electronic address: Tannazsfm@gmail.com.
  • Paiva-Santos AC; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Electronic address: Acsantos@ff.uc.pt.
  • Peixoto D; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Electronic address: Dianacpeixoto@gmail.com.
  • Veiga F; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Electronic address: Fveiga@ff.uc.pt.
  • Hamishehkar H; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Hamishehkarh@tbzmed.ac.ir.
  • Zeinali M; Student Research Committee and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Research and Development Unit, Daana Pharma Co, Tabriz, Iran. Electronic address: zeinalim@tbzmed.ac.ir.
  • Abbaspour-Ravasjani S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Abbaspour.s@tbzmed.ac.ir.
Int J Pharm ; 624: 122027, 2022 Aug 25.
Article in En | MEDLINE | ID: mdl-35850183
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nanostructures / Lung Neoplasms Limits: Humans Language: En Journal: Int J Pharm Year: 2022 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nanostructures / Lung Neoplasms Limits: Humans Language: En Journal: Int J Pharm Year: 2022 Document type: Article Country of publication: Netherlands